Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 20,2x - 22,4x | 21,3x |
| Selected Fwd EBITDA Multiple | 15,8x - 17,4x | 16,6x |
| Fair Value | ﷼123,27 - ﷼137,69 | ﷼130,48 |
| Upside | 3,2% - 15,3% | 9,3% |
| Benchmarks | Ticker | Full Ticker |
| Mouwasat Medical Services Company | 4002 | SASE:4002 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Almoosa Health Company | 4018 | SASE:4018 |
| Middle East Healthcare Company | 4009 | SASE:4009 |
| Dallah Healthcare Company | 4004 | SASE:4004 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| 4002 | 4007 | 4013 | 4018 | 4009 | 4004 | ||
| SASE:4002 | SASE:4007 | SASE:4013 | SASE:4018 | SASE:4009 | SASE:4004 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 9.4% | 10.5% | 20.3% | NM- | 26.1% | 24.2% | |
| 3Y CAGR | 7.3% | 19.5% | 16.2% | 42.4% | 50.3% | 14.2% | |
| Latest Twelve Months | -0.3% | -4.8% | 18.4% | 45.7% | 14.0% | 13.3% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 35.5% | 31.0% | 23.9% | 18.2% | 15.5% | 20.6% | |
| Prior Fiscal Year | 36.0% | 36.7% | 24.8% | 18.7% | 18.8% | 20.7% | |
| Latest Fiscal Year | 33.2% | 34.0% | 24.2% | 21.4% | 21.8% | 21.3% | |
| Latest Twelve Months | 33.4% | 33.6% | 24.1% | 22.2% | 21.2% | 21.8% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.30x | 5.40x | 8.56x | 5.95x | 2.82x | 4.08x | |
| EV / LTM EBITDA | 15.8x | 16.1x | 35.6x | 26.8x | 11.2x | 18.7x | |
| EV / LTM EBIT | 20.9x | 20.2x | 41.8x | 37.1x | 15.1x | 22.3x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 11.2x | 16.1x | 35.6x | ||||
| Historical EV / LTM EBITDA | 21.5x | 22.1x | 29.7x | ||||
| Selected EV / LTM EBITDA | 20.2x | 21.3x | 22.4x | ||||
| (x) LTM EBITDA | 710 | 710 | 710 | ||||
| (=) Implied Enterprise Value | 14,354 | 15,109 | 15,864 | ||||
| (-) Non-shareholder Claims * | (1,384) | (1,384) | (1,384) | ||||
| (=) Equity Value | 12,969 | 13,725 | 14,480 | ||||
| (/) Shares Outstanding | 101.2 | 101.2 | 101.2 | ||||
| Implied Value Range | 128.16 | 135.63 | 143.09 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 128.16 | 135.63 | 143.09 | 119.40 | |||
| Upside / (Downside) | 7.3% | 13.6% | 19.8% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4002 | 4007 | 4013 | 4018 | 4009 | 4004 | |
| Enterprise Value | 15,394 | 6,371 | 101,230 | 7,485 | 7,870 | 13,467 | |
| (+) Cash & Short Term Investments | 700 | 245 | 2,548 | 385 | 282 | 175 | |
| (+) Investments & Other | 0 | 0 | 469 | 9 | 60 | 1,793 | |
| (-) Debt | (801) | (304) | (8,587) | (614) | (2,391) | (3,069) | |
| (-) Other Liabilities | (153) | 0 | (461) | 0 | (50) | (283) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 15,140 | 6,312 | 95,200 | 7,266 | 5,771 | 12,083 | |
| (/) Shares Outstanding | 200.0 | 160.0 | 350.0 | 44.3 | 92.0 | 101.2 | |
| Implied Stock Price | 75.70 | 39.45 | 272.00 | 164.00 | 62.70 | 119.40 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 75.70 | 39.45 | 272.00 | 164.00 | 62.70 | 119.40 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |